Document is current
Any future updates will be listed below
-
Authors
Gillis, Sophie https://orcid.org/0009-0008-7027-8872
Phelan, Emma https://orcid.org/0009-0004-5285-753X
Pitman, Jennifer https://orcid.org/0000-0002-7250-1600
Trenaman, Shanna https://orcid.org/0000-0002-7982-4437
Battistella, Marisa https://orcid.org/0000-0001-9456-4365
Sanyal, Chiranjeev https://orcid.org/0000-0003-3677-8036
Daley, Christopher https://orcid.org/0000-0002-9002-5011
Tennankore, Karthik https://orcid.org/0000-0002-7919-6709
Gillis, Louise https://orcid.org/0000-0001-8250-5886
Wilson, Jo-Anne https://orcid.org/0000-0003-3423-5740
- License Information
-
More Information
Article History
Received: 28 September 2025
Accepted: 17 January 2026
First Online: 24 February 2026
Declarations
:
: Authors S.G, E.P, J.P, S.T, C.S, C.D, L.G have no financial interests. Author J.W. has received moderator honorarium from Otsuka and has received unrestricted investigator-initiated grant funding from Bayer Canada. Author K.T. has received honorarium for advisory board with Otsuka, Bayer, and Vifor Pharmaceuticals; has received unrestricted investigator-initiated grant funding from Otsuka. Autor M.B has received honorarium from Otsuka, and Bayer Canada.
: Institutional ethics approval was not required for this scoping review. The study was registered with Open Science Framework.
: Not applicable.
: All authors consent to publish.
